Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Hancock Jaffe Laboratories Inc (NQ: HJLI)
0.4350 USD  -0.0150 (-3.33%)
Streaming Delayed Price  /  Updated: 4:00 PM EST, Dec 13, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 84,947
Open 0.4700
Bid (Size) 0.4350 (4)
Ask (Size) 0.4351 (11)
Prev. Close 0.4500
Today's Range 0.3800 - 0.4700
52wk Range 0.3820 - 3.450
Shares Outstanding 11,192,951
Dividend Yield N/A
Performance
YTD
-72.64%
-72.64%
1 Month
-26.27%
-26.27%
3 Month
-55.15%
-55.15%
6 Month
-59.72%
-59.72%
1 Year
-75.83%
-75.83%
Top News
More News
Hancock Jaffe Medical Team to Make Presentations at 46th Annual VEITH Vascular Symposium November 19 to November 23 in New York City
from ACCESSWIRE
Hancock Jaffe Enrolls and Successfully Implants Tenth VenoValve Patient
from ACCESSWIRE
More News
Read More
Principal Investigator Dr. Jorge Hernando Ulloa Presents 6 Month VenoValve Data at the 20th Congress of Asian Society for Vascular Surgery
from ACCESSWIRE
Principal Investigator Dr. Jorge Hernando Ulloa to Present VenoValve Six Month Data at the 20th Congress of Asian Society for Vascular Surgery on October 25, 2019
from ACCESSWIRE
Hancock Jaffe to Present at the Inaugural MicroCap Rodeo Investor Conference on October 16, 2019
from ACCESSWIRE
Hancock Jaffe to Host Virtual Roadshow Webinar on Thursday, October 3, 2019 at 4:30 p.m. Eastern Time
from ACCESSWIRE
Hancock Jaffe Appoints Global Healthcare Executive Matthew Jenusaitis and Financial and Medical Reimbursement Expert Robert Gray to its Board of Directors
from ACCESSWIRE
Hancock Jaffe Medical Advisory Board Member Dr. Steven Elias Presents at International Union of Phlebology Conference in Krakow, Poland
from ACCESSWIRE
Hancock Jaffe to Present at H.C. Wainwright 21st Annual Global Investment Conference on September 9, 2019
from ACCESSWIRE
Hancock Jaffe Successfully Completes Two Additional VenoValve Implantations for First-in-Man Study
from ACCESSWIRE
Hancock Jaffe Reports Positive 90 Day Results for CoreoGraft Animal Feasibility Study
from ACCESSWIRE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.